Yuen-Yi Tseng
机构: Broad Institute of MIT and Havard
每年引用次数
引用次数
引用: 6,326
H-指数: 18
I10-指数 : 20
出版物: 61
Adjacent long non-coding RNA PVT1 and MYC co-operate in breast cancer with gain of 8q24
Yuen-Yi Tseng
2013
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development
Krinio Giannikou , Izabela A Malinowska , Trevor J Pugh , Rachel Yan
PLOS
2016
Abstract PR04: Integration of CRISPR-Cas9, RNAi and pharmacologic screens identify actionable targets in a rare cancer
Andrew L Hong , Yuen-Yi Tseng , Glenn Cowley , Oliver Jonas
Clinical Cancer Research 22
2016
Abstract B26: Accelerating prediction of tumor vulnerabilities using next-generation cancer models
Yuen-Yi Tseng , Paula Keskula , Andrew L. Hong , Shubhroz Gill
Clinical Cancer Research 22
2016
Caenorhabditis elegans expresses a functional ArsA
Yuen-Yi Tseng , Chan-Wei Yu , Vivian Hsiu-Chuan Liao
FEBS Journal 274 ( 10) 2566 -2572
23
2007
The PVT1-MYC duet in cancer
Yuen-Yi Tseng , Anindya Bagchi
Molecular and Cellular Oncology 2 ( 2)
32
2015
From cell lines to living biosensors: new opportunities to prioritize cancer dependencies using ex vivo tumor cultures.
Yuen-Yi Tseng , Jesse S Boehm
Current Opinion in Genetics & Development 54 33 -40
18
2019
Abstract PR01: Long noncoding RNA PVT1 potentiates MYC in human cancers with 8q24 gain
Yuen-Yi Tseng , Anindya Bagchi
Molecular Cancer Research 13
2015
Activation of endothelial cells to pathological status by down-regulation of connexin43.
Hsueh-Hsiao Wang , Chang-I Kung , Yuen-Yi Tseng , Yi-Chun Lin
Cardiovascular Research 79 ( 3) 509 -518
69
2008
Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition.
Andrew L Hong , Yuen-Yi Tseng , Jeremiah A Wala , Won-Jun Kim
eLife 8
32
2019
HIF-2α drives an intrinsic vulnerability to ferroptosis in clear cell renal cell carcinoma
Yilong Zou , Michael J. Palte , Amy A. Deik , Haoxin Li
bioRxiv 388041
4
2018
Abstract B38: Developing a functional genomics platform to interrogate rare pediatric cancers
Andrew L. Hong , Glenn S. Cowley , Yuen-Yi Tseng , Jaime H. Cheah
Cancer Research 76
2016
Abstract B18: Modeling renal medullary carcinomas identifies druggable vulnerabilities in SMARCB1-deficient cancers
Andrew L. Hong , Yuen-Yi Tseng , Bryan D. Kynnap , Mihir B. Doshi
Cancer Research 78
2018
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Jill P. Mesirov , Daniel A. Haber , Jeffrey A. Engelman , Jesse S. Boehm
Nature 547 ( 7664) 453 -457
414
2017
Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood
Julia Joung , Jesse M. Engreitz , Silvana Konermann , Omar O. Abudayyeh
Nature 548 ( 7667) 343 -346
342
2017
Assessment of heavy metal bioavailability in contaminated sediments and soils using green fluorescent protein-based bacterial biosensors.
Vivian Hsiu-Chuan Liao , Ming-Te Chien , Yuen-Yi Tseng , Kun-Lin Ou
Environmental Pollution 142 ( 1) 17 -23
127
2006
C-reactive protein, sodium azide, and endothelial connexin43 gap junctions.
Hsueh-Hsiao Wang , Hung-I Yeh , Chi-Young Wang , Cheng-Huang Su
Cell Biology and Toxicology 26 ( 2) 153 -163
1
2010
Patient-derived xenografts undergo mouse-specific tumor evolution.
Uri Ben-David , Gavin Ha , Yuen-Yi Tseng , Noah F Greenwald
Nature Genetics 49 ( 11) 1567 -1575
592
2017
MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer.
Aaron L. Sarver , Collin D. Murray , Nuri A. Temiz , Yuen-Yi Tseng
Cell Cycle 15 ( 7) 881 -885
18
2016
Abstract B17: Identification of Druggable Targets through Functional Multi-Omics in Renal Medullary Carcinoma
Andrew L. Hong , Yuen-Yi Tseng , Bryan D. Kynnap , Mihir B. Doshi
Molecular Cancer Therapeutics 16
2017